NCT03391141 is a clinical trial in Obstructive Sleep Apnea, sponsored by Dr. Erica Thaler.

Who is sponsoring NCT03391141?

NCT03391141 is sponsored by Dr. Erica Thaler.

What condition does NCT03391141 study?

NCT03391141 studies Obstructive Sleep Apnea.

Is NCT03391141 still recruiting?

NCT03391141 is currently completed. Last updated 30 September 2021.

Last reviewed 2021-09-30 · How we verify

NCT03391141

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Validation of Drug-Induced Sleep Endoscopy (DISE)

Completed Last updated 30 September 2021

What this trial tests

trial in Obstructive Sleep Apnea in 34 participants. Completed in 1 September 2021.

Timeline

9 April 2018

Primary endpoint
1 September 2021

1 September 2021

Quick facts

Lead sponsor	Dr. Erica Thaler
Status	Completed
Study type	OBSERVATIONAL
Enrollment	34
Start date	9 April 2018
Primary completion	1 September 2021
Estimated completion	1 September 2021
Sites	1 location across United States

Conditions studied

Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →

Sponsor

Dr. Erica Thaler

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to validate whether the pattern of airway collapse recorded during Drug-Induced Sleep Endoscopy (DISE) mirrors that of natural sleep, and to develop a model for airway collapse. Sensors will be placed in subjects' upper airways during DISE and then during in-lab sleep studies. The sleep study results will be compared with OR findings to create an aerodynamic model for natural sleep and to assess whether airway observations during DISE were valid representations of natural sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03391141 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Erica Thaler
Last refreshed: 30 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03391141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing